In the Face of a Pandemic, Can Pharma Shift Gears?

N. Craig Smith, Markus Schölz

    Research output: Contribution to journalArticle


    The pharmaceutical industry’s competition-based model could be a real liability in the race to develop drugs and vaccines to combat COVID-19. A better approach would be for pharma companies and partners outside the industry to temporarily hit the pause button on their traditional ways of doing business and find new ways to work together, as some scientists are now advocating.
    Original languageEnglish
    JournalMIT Sloan Management Review
    Publication statusPublished - 16 Apr 2020


    • Pharmaceuticals
    • Pandemic
    • Breakthrough Innovation
    • Vaccines
    • Collaboration


    Dive into the research topics of 'In the Face of a Pandemic, Can Pharma Shift Gears?'. Together they form a unique fingerprint.

    Cite this